Sarvodaya Hospital, Faridabad Becomes India's First Theranostics Center to Offer Terbium-161 PSMA Therapy for Advanced Prostate Cancer Patients
Jun 02, 2025
New Delhi [India], June 2: Reinforcing its commitment to pioneering advanced cancer care, Sarvodaya Hospital, Faridabad, Delhi NCR is proud to announce that it has become the first Theranostics and Nuclear Medicine center in India to offer Terbium-161 PSMA therapy for prostate cancer treatment. This marks a significant milestone, positioning Sarvodaya Hospital as a leader in providing comprehensive cancer care. Furthermore, this cutting-edge nuclear therapy represents a notable step in cancer treatment, offering new hope to patients with advanced metastatic castration resistant/hormone refractory prostate cancer.
Read More ..
